KZR-261 in Subjects With Advanced Solid Malignancies
NCT05047536
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
61
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor decision.
Conditions
Advanced/Metastatic Solid Tumor
Interventions
DRUG:
KZR-261
Sponsor
Kezar Life Sciences, Inc.